AtezolizumabLeukoderma, vitiligo and halo nevi: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1694卷 / 1期

关键词：

D O I：

10.1007/s40278-018-43467-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：66 / 66

相关论文

共 50 条

[31] AfamelanotideLentigines and nevi: case report
Reactions Weekly, 2011, 1364 (1) : 6 - 6
[32] ImatinibHalo nevi: case report
Reactions Weekly, 2010, 1311 (1) : 28 - 28
[33] ImatinibEruptive nevi: case report
Reactions Weekly, 2021, 1874 (1) : 127 - 127
[34] NatalizumabMelanocytic nevi: case report
Reactions Weekly, 2012, 1419 (1) : 36 - 36
[35] A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin
Gao-Zhong Ding
Wen-E Zhao
Xue Li
Qing-Li Gong
Yan Lu
Archives of Dermatological Research, 2015, 307 : 281 - 289
[36] IsotretinoinBlue nevi: case report
Reactions Weekly, 2019, 1765 (1) : 208 - 208
[37] PembrolizumabHalo nevi: case report
Reactions Weekly, 2019, 1756 (1) : 277 - 277
[38] TocilizumabEruptive nevi: case report
Reactions Weekly, 2018, 1708 (1) : 304 - 304
[39] AfamelanotideMelanocytic nevi: case report
Reactions Weekly, 2009, 1274 (1) : 6 - 6
[40] A case of eruptive halo nevi following COVID-19
Gonullu, O.
Cebeci, F.
Ozen, T.
Gurel, M. S.
Simsek, B. c.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023,

← 1 2 3 4 5 →